Houston pharma co. shakes up C-suite again

Houston-based Bellicum Pharmaceuticals Inc. continues to rearrange its C-suite.

Bellicum (Nasdaq: BLCM), a pharmaceutical company focusing on the treatment of specific types of cancer, named Dr. Gregory Naeve as its chief business officer, according to a release. His position is effective Aug. 21.

Naeve’s appointment occurs after Annemarie Moseley announced in May plans to step down as the company’s COO and executive vice president of clinical development. In January, the company named Rick Fair…

Houston pharma co. shakes up C-suite again syndicated post

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s